Income Statement

v3.20.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Total Net Revenues $ 11,982,196 $ 8,431,979
Total Cost of Sales 7,004,994 4,662,086
Gross Profit 4,977,202 3,769,893
Operating Expenses:    
Research and development 1,737,385 1,879,676
Selling, general and administrative 5,155,092 4,843,859
Depreciation and amortization 66,082 67,107
Total Operating Expenses 6,958,559 6,790,642
Operating Loss (1,981,357) (3,020,749)
Other Income (Expenses):    
Gain on sale of fixed assets 150 0
Interest income (expense), net (53,289) 13,622
Total Other Income (Expense) (53,139) 13,622
Loss before Provision for Income Taxes (2,034,496) (3,007,127)
Provision for Income Taxes (100,363) 9,623
Net Loss Attributable to Common Stockholders $ (1,934,133) $ (3,016,750)
Net Loss per Common Share:    
Basic - net loss attributable to common stockholders $ (0.01) $ (0.02)
Diluted - net loss attributable to common stockholders $ (0.01) $ (0.02)
Weighted Average Common Shares Outstanding used in computing basic net loss per share 135,213,641 134,055,098
Weighted Average Common Shares Outstanding used in computing diluted net loss per share 135,213,641 134,055,098
Product [Member]    
Total Net Revenues $ 11,212,854 $ 7,616,415
Total Cost of Sales 6,703,494 4,392,643
Recurring [Member]    
Total Net Revenues 769,342 815,564
Total Cost of Sales $ 301,500 $ 269,443

Source